We have used the yeast two-hybrid system to identify proteins that interact with Vav, a GDP/GTP exchange factor for the Rac-1 GTPase that plays an important role in cell signaling and oncogenic transformation. This experimental approach resulted in the isolation of Cbl-b, a signal transduction molecule highly related to the mammalian c-cbl proto-oncogene product and to the C. 
Introduction
The vav gene was ®rst identi®ed by virtue of its oncogenic activation during the course of gene transfer assays (Katzav et al., 1989) . Its normal allele, the vav proto-oncogene, encodes a 95 kDa polypeptide that harbors a complex array of structural domains, including leucine-rich, acidic, Dbl-homology (DH), pleckstrin-homology (PH), cysteine-rich, SH3 and SH2 domains (for a review, see Bustelo 1996) . The important role of this gene during mitogenic and ontogenic processes was demonstrated by both cell biology and genetic experiments. Thus, it has been shown that Vav can induce high levels of morphological transformation in rodent ®broblasts after deletion of N-terminal sequences (Katzav et al., 1989; Coppola et al., 1991) . Moreover, disruption of the vav locus by homologous recombination techniques results in severe signaling defects of primary antigen receptors, leading to abnormal lymphocyte proliferation and lymphocytopenia (Fisher et al., 1995; Tarakhovski et al., 1995; Zhang et al., 1995) . In T-cells this phenotype appears to be mediated, at least in part, by insucient IL-2 secretion after T-cell receptor cross-linking (Tarakhovski et al., 1995; Zhang et al., 1995) .
At the biochemical level, Vav becomes tyrosine phosphorylated upon stimulation of hematopoietic receptors such as the T-cell receptor-CD4 complex Margolis et al., 1992) , the mast cell IgE high anity receptor (Margolis et al., 1992) , the B-cell IgM antigen complex , the c-Kit and Flk-2 tyrosine kinase receptors (Alai et al., 1992; Dosil et al., 1993) and a large panel of cytokine receptors (Bustelo, 1996) , further suggesting that the function of Vav is required during the earliest steps of receptor-mediated signal transduction.
Recent experimental evidence indicates that Vav acts as a guanosine-nucleotide exchange factor for the GTP-binding protein Rac-1 (Crespo et al., 1997) , a GTPase of the Rho subfamily with roles in cytoskeletal architecture, cell proliferation, and cellular transformation (for a review, see Ridley, 1995) . This enzymatic activity is stimulated during cell signaling by the phosphorylation of Vav on tyrosine residues, leading to the transition of the Rac-1 GTPase from the inactive (GDP-loaded) to the active (GTP-loaded state) (Crespo et al., 1997) . Rac-1 activation leads in turn to the stimulation of intracellular routes such as the c-Jun Nterminal kinase (JNK) pathway (Crespo et al., 1996 (Crespo et al., , 1997 . This biochemical activity appears to be mediated by the Vav DH domain, since mutants of Vav with a non-functional DH motif do not induce Rac-1 nucleotide exchange nor JNK activation (Crespo et al., 1996 (Crespo et al., , 1997 .
In addition to this catalytic role, other experimental evidence suggests that protein-protein interactions also take part in the regulation of Vav activity. In agreement with this notion, several reports have indicated that the Vav SH2 and SH3 domains work as autonomous heterodimerization motifs. As an example, the Vav SH2 domain binds to ligandstimulated mitogenic receptors such as the EGF and PDGF receptors Margolis et al., 1992) as well as to cytoplasmic tyrosine-phosphorylated proteins such as the B-cell speci®c Vap-1 protein , the T-cell speci®c Zap70 protein tyrosine kinase (Katzav et al., 1994) , members of the Jak and Btk families (Machide et al., 1995; Matsuguchi et al., 1995) and the hematopoietic-speci®c SLP-76 protein (Wu et al., 1996) . These interactions are likely to be mediated by the speci®c recognition of the tyrosine phosphorylated YXEP (where X=M, L or E) sequence motif by the Vav SH2 domain (Songyang et al., 1994) . On the other hand, the Vav SH3 domains have been identi®ed as targets for the association of a plethora of quite unrelated proteins such as Grb-2 (Ye and Baltimore, 1994), hnRNP-K (Hobert et al., 1994; Bustelo et al., 1995) , the nuclear protein Ku-70 (Romero et al., 1996) and the cytoskeletal protein zyxin (Hobert et al., 1996) . These interactions are mediated by the recognition of speci®c proline-rich sequences by the Vav SH3 domains. Since these interactions do not require post-translational modification of these proteins, they are likely to be constitutive and independent of the mitogenic status of cells. At present, the biological signi®cance of these interactions remains to be determined.
In this study, we have utilized the SH3-SH2-SH3 domain of Vav as a probe to isolate novel Vav-binding proteins by the two hybrid system (Bartel et al., 1993) . This approach resulted in the identi®cation of two Vav-binding proteins, the already-described hnRNP-K (Hobert et al., 1994; Bustelo et al., 1995) and a second protein, designated Cbl-b (Keane et al., 1995) , whose characterization is presented in this work. Cbl-b is a ubiquitously-expressed protein that binds to the carboxy-terminal region of Vav through an interaction mediated by a cluster of proline-rich sequences located in the middle of the Cbl-b molecule. In addition, we show that overexpression of full length Cbl-b results in the inhibition of the Vav signaling pathway that triggers JNK activation. Cbl-b is highly related to the mammalian c-Cbl and the nematode Sli-1 proteins (for a review, see Langdon, 1995) . c-Cbl is the cellular homologue of v-cbl, a retroviral oncogene implicated in the development of pre-B lymphomas and myelogenous leukemia in mice that also induces acute transformation of immortalized rodent ®broblasts in vitro (Langdon, 1995) . The Sli-1 protein has been recently identi®ed as the product of a dominant inhibitor of the C. elegans let23 gene, a homologue of the mammalian EGF receptor (Langdon, 1995) . Hence, Cbl-b appears to be a member of an evolutionarily conserved family of proteins implicated in downregulating signals derived from tyrosine kinase receptors and/or their associated substrates.
Results

Isolation and characterization of the cbl-b gene
To isolate cDNAs whose protein products interact with Vav protein, we fused the carboxy-terminal region of mouse vav gene to the Gal-4 DNA-binding domain (GBD) in a vector (pGBT) that directs low levels of expression of the GBD fusion proteins (Bustelo et al., 1995) . As the tester strain, we used YPB2 derivatives containing the bait plasmid and two Gal-4-inducible markers, HIS3 and lacZ (Bartel et al., 1993) . This tester strain was re-transformed with a cDNA library derived from human B-lymphocytes constructed in the pACT plasmid (Bartel et al., 1993) , a vector that directs the synthesis of fusion proteins containing the Gal-4 transcriptional activation domain (GAD). In those cases where a GAD fusion protein interacts with the bait protein, a functional Gal-4 activity is reconstituted leading to histidine prototrophy (HIS3) and b-galactosidase expression (lacZ) (Bartel et al., 1993) .
A total of 2.9610 6 transformants were placed in selective media containing 15 mM 3-amino-1,2,4-triazole. Transformants showing histidine prototrophy after one week of culture were subsequently screened for the ability to produce b-galactosidase using a ®lter lift assay, resulting in a total of 30 positives. To test whether the phenotypes of those clones were dependent on the interaction with the GBD-Vav SH3-SH2-SH3 fusion protein, the plasmids of those colonies were selectively recovered in bacteria, grouped in three families by Southern blot hybridization, and representatives of each family re-introduced in YPB2 cells with vectors encoding the Gal-4 DNA binding domain either alone or fused to the Vav SH3-SH2-SH3 region. As additional control, we performed parallel experiments with a GBD fusion protein containing the SH3-SH2-SH3 region of Vav-2, a Vav-related protein with transforming potential that displays an ubiquitous distribution (Schuebel et al., 1996) . As illustrated in Figure 1a , the co-transformation of one of the library plasmids (pXRB85) with either the Vav or Vav-2 Cterminal domains induced comparable levels of transcriptional activation of the lacZ gene. This transactivation was as strong as that observed with the interaction between the yeast SNF4 and SNF1 protein ( Figure 1a) . As a control for the speci®city of the interaction, neither Vav-2 nor Vav could trigger detectable b-galactosidase activity when co-transfected with the non-chimeric GAD protein (Figure 1a) . Likewise, no transactivation was observed when pXRB85 was co-expressed with the DNA binding domain of Gal-4 protein ( Figure 1a) . Subsequent experiments indicated that Vav and the protein encoded by pXRB85 were capable of interacting in unrelated techniques such as GST-pull down experiments and farwestern blot analysis, further demonstrating the speci®city of the initial two-hybrid association. By contrast, the members of the other families of putative positive clones did not show any binding in those two alternative systems and were consequently discounted as Vav-interacting partners (data not shown).
Nucleotide sequence analysis revealed that the cDNA present in the pXRB85 plasmid encoded a 456 amino acid-long polypeptide identical to residues 526 ± 982 of Cbl-b (Keane et al., 1995) (Figure 1b) , a molecule identi®ed during the initial characterization of our clone that belongs to the c-Cbl/Sli-1 family of signal transduction molecules (Langdon, 1995) . Members of this protein family are characterized by the presence of a highly conserved amino-terminal region that we will describe here as Cbl-homology (CH) region, a central zinc ®nger domain of the C3HC4/ RING subclass, and a C-terminal proline-rich region of variable length that displays lower conservation (Figure 1b) . Cloning of the full length cbl-b cDNA from a human fetal brain cDNA library (see Materials and methods) resulted in the isolation of several cDNAs encoding a 982 amino acid-long protein that displayed only three amino acid changes (G210S, C266Y and T487A) with respect to the sequence originally reported by Keane et al. (1995) . Whether these dierences are due to polymorphic sequences remains to be determined.
To determine the pattern of expression of the cbl-b gene, we performed Northern hybridization analysis of polyA mRNAs from various human tissues. To avoid cross-hybridization with the highly related c-cbl mRNAs, we used as a probe the cbl-b cDNA fragment contained in our two-hybrid isolate (pXRB85), a region which displays the lowest homology to the other members of the Cbl family. We observed cbl-b mRNA expression in every tissue examined, with slightly higher levels in placenta, heart and tissues of the reproductive system ( Figure 2 S-labeled Cbl-b polypeptide (residues 476 ± 982) with various GST fusion proteins corresponding to the carboxy-terminal motifs of Vav ( Figure 3A ). As a positive control, we used in vitro translated hnRNP-K, a protein previously shown to interact with the carboxy-terminal SH3 domain of Vav (Hobert et al., 1994; Bustelo et al., 1995) . As illustrated in Figure 3B , the complete SH3-SH2-SH3 motif, but not its individual domains, was capable of interacting with the Cbl-b protein. This observation contrasts with our previous results obtained with the hnRNP-K protein (Bustelo et al., 1995) , which requires only the most carboxy-terminal SH3 domain of Vav for ecient binding ( Figure 3B , lane d).
To determine the Vav binding site in the Cbl-b molecule, we next analysed the interaction of a 32 Plabeled GST/VavSH3-SH2-SH3 protein to GST fusion proteins containing dierent regions of Cbl-b ( Figure  4A ). As a positive control, we used a GST protein containing the ®rst Vav-binding site of hnRNP-K ( Figure 4C ) (Bustelo et al., 1995) . Negative controls included GST alone as well as a chimeric GST fused to full length RhoA. Farwestern blot analysis indicated that the Vav SH3-SH2-SH3 probe recognized the GST fusion protein containing a stretch of proline-rich Figure 4B , lanes a ± c). These results indicate that the proline-rich sequences spanning residues 543 ± 568 of Cbl-b are the minimal structural elements required for binding to Vav ( Figure 4C ). Interestingly, this region contains a motif, R-X-P (6) -X-R, shared by one of the proline-rich regions of hnRNP-K that mediate its interaction with Vav ( Figure 4C ) (Bustelo et al., 1995) . The second hnRNP-K prolinerich domain involved in Vav binding also contains a cluster of six prolines in the core of the binding site ( Figure 4C ).
In vivo binding of Vav and Cbl-b proteins
To determine whether the Cbl-b and Vav proteins associate in vivo, we conducted a series of coimmunoprecipitation experiments using NIH3T3 cell lines expressing Vav alone and in combination with the Cbl-b protein tagged at its amino-terminus with the FLAG epitope. As negative controls, we used NIH3T3 clones containing Cbl-b and Grb-2, a signal transduction protein whose structure closely resembles the SH3-SH2-SH3 carboxy-terminal region of Vav (Suen et al., 1993) . The resulting Cbl-b immunoprecipitates were probed with anti-FLAG antibodies to determine expression levels of the Cbl-b protein and, subsequently, re-blotted with anti-Vav antibodies. As illustrated in Figure 5a (lower panel), Vav was readily detected in the Cbl-b immunocomplexes derived from exponentially growing cells, indicating that these proteins form heteromolecular complexes in vivo. Anti-FLAG immunoprecipitates derived from cell lines that express Vav, but not Cbl-b, did not show any signi®cant levels of Vav. Notably, the amount of Vav in the anti-FLAG immunoprecipitates was proportional to the amount of Cbl-b present in these samples ( Figure 5a , upper panel), suggesting that their co-immunoprecipitation is concentration-dependent.
To con®rm the speci®city of this interaction, we examined the presence of the Vav protein in anti-FLAG immunoprecipitates obtained either in the absence or presence of competing FLAG peptide (10 mg/ml). As an additional control, we analyzed parallel immunoprecipitates obtained with an unrelated S-labeled proline-rich region (residues 476 ± 982) of Cbl-b and the full length hnRNP-K protein were generated by in vitro translation and incubated at 48C for 2 h with 5 mg of the above GST fusion proteins or GST alone. The resulting complexes were fractionated by SDS ± PAGE (8%), ®xed and soaked in Enlightning (NEN). Dried gels were exposed overnight (7708C) to autoradiographic ®lms. The migration of Cbl-b and hnRNP-K is indicated by arrows To this end, we determined the phosphorylation levels of Cbl-b in resting and mitogen-stimulated NIH3T3 cells by anti-phosphotyrosine immunoblot analysis. As expected, Vav became highly phosphorylated on tyrosine residues upon treatment of these cells with either EGF or PDGF Margolis et al., 1992) (Figure 6 ). However, we could not detect signi®cant tyrosine phosphorylation of Cbl-b under the same experimental conditions. Cbl-b immunoprecipitates contained tyrosine phosphorylated proteins of 95 and 180 kDa in EGF-stimulated cells and of 95 and 190 kDa in PDGF-stimulated cells (Figure 6 ). The mobility of these proteins is reminiscent of those of Vav and the autophosphorylated EGF-and PDGFreceptors that co-immunoprecipitated with Vav upon ligand stimulation . Western blot analysis using speci®c antibodies demonstrated that indeed these tyrosine-phosphorylated proteins were Vav (95 kDa), EGF receptor (180 kDa) and PDGF receptor (190 kDa) (data not shown). These results indicate that Cbl-b forms a trimeric complex with Vav and, depending on the mitogen used, either the EGF or PDGF receptor.
To determine whether the association between Vav and Cbl-b was aected by the mitogenic state of the cells, the same anti-FLAG immunoprecipitates were submitted to Western blot analysis using an anti-Vav antiserum ( 
Cbl-b overexpression inhibits Vav-mediated JNK stimulation
Recent genetic analysis in nematodes has indicated that the product of the sli-1 gene down modulates the activity of Let23, the C. elegans homologue of the mammalian EGF receptor (Yoon et al., 1995) . These observations prompted us to analyse whether (7) or presence (+) of competing FLAG peptide (CP) (10 mg/ml). The resulting immunocomplexes were submitted to Western blot analysis using anti-FLAG (upper panel) or anti-Vav (lower panel) antibodies as described above. The migration of Cbl-b, Vav, and immunoglobulin heavy chains (IgG) is indicated by arrows. Co-electrophoresed molecular weight markers include myosin (200 000), phosphorylase b (97 000), bovine seroalbumin (69 000) and ovoalbumin (46 000) Cbl-b could also act as a dominant inhibitor of the signal transduction pathway regulated by Vav. We investigated therefore the eect of Cbl-b on the activation of JNK, a downstream element of the Vav signaling pathway (Crespo et al., 1996 (Crespo et al., , 1997 . To this end, a hematoagglutinin-tagged version of JNK and Vav were co-expressed in COS-7 either alone or in combination with Cbl-b. As a control, HA-JNK and Cbl-b were expressed in the presence of MEKK, a well known upstream activator of JNK (Coso et al., 1995) . After transfection, cells were lysed, HA-JNK immunoprecipitated using anti-HA antibodies, and its catalytic activity determined in an in vitro kinase reaction using [g-32 P]ATP and a GST/ ATF-2 (residues 1 ± 96) fusion protein as exogenous substrate. Labeled proteins were separated by SDS ± PAGE and the incorporation of 32 P into the GST/ ATF-2 evaluated by autoradiography. In agreement with our previous observations (Crespo et al., 1996) , the co-expression of Vav and JNK leads to a tenfold increase in the catalytic activity of this protein kinase (Figure 7a ). Co-expression of Cbl-b abrogates this activation, leading to levels of JNK activity similar to those found in cells in which JNK is transfected alone (Figure 7a ). In contrast, Cbl-b does not have any signi®cant eect on the activation of JNK by MEKK (Figure 7a ), a result that illustrates the speci®city of the inhibitory action of Cbl-b on Vav signaling.
To further dissect the molecular events behind this biological eect, we determined the inhibitory activity of a number of Cbl-b mutants on Vav-mediated JNK activation (Figure 7b ). These proteins included truncations of Cbl-b lacking either the N-(residues 1 ± 463) or C-terminal (residues 482 ± 982) regions and two missense mutations (G298E and G298K) similar to those found in loss-of-function mutants of the sli-1 gene (Yoon et al., 1995) . As shown in Figure 7c , neither of these constructs were capable of aecting the activation of JNK mediated by Vav. This result suggested that inhibition of Vav activity requires the presence of a full-length Cbl-b protein with a fully functional CH domain.
Discussion
In this study, we report the identi®cation of Cbl-b as a novel Vav-binding protein.
The interaction between Cbl-b and Vav is mediated by the recognition of proline-rich regions in Cbl-b by the carboxy-terminal SH3 domains of Vav, the same structural elements previously described for the interaction of Vav with other proteins such as hnRNP-K. The proline-rich domain of Cbl-b contains a palindromic consensus motif composed of a hexaproline core¯anked by two positively charged amino acids (R-X-P (6) -X-R), a structure that closely resembles the class II SH3 binding sites of other signaling proteins. The presence of such a high content on proline residues is likely to contribute to the generation of left handed type II (PPII) helices, the optimal conformation for SH3 domain binding (Yu et al., 1994) . Despite this apparent similarity, the interaction of Vav with Cbl-b and hnRNP-K reveals important structural dierences. Whereas binding of Vav to hnRNP-K can be mediated by either of the two hnRNP-K hexaproline-containing regions, its association with Cbl-b requires multiple proline-rich regions. In addition, binding of Vav to Cbl-b needs the complete carboxy-terminal region instead of a single SH3 domain as in the case of hnRNP-K. These ®ndings suggest that the two Vav SH3 domains act synergistically, perhaps by binding to cooperating proline-rich sequences in Cbl-b. The structural nature of the association between Vav and Cbl-b is further complicated by the observation that the anity between these proteins increases upon tyrosine phosphorylation of Vav and/or SH2-mediated binding to tyrosine phosphorylated receptors, suggesting that other conformational and/or subcellular localization changes contribute to the establishment of a tight interaction between these two signaling molecules.
In vitro experiments indicate that Cbl-b also binds to Vav-2, a new oncoprotein that not only has a remarkable sequence homology with Vav (55% overall sequence identity) but also displays each of the known structural motifs of Vav in the same spatially related manner (Schuebel et al., 1996) . However, unlike Vav, Vav-2 is expressed at very high levels during embryonic development and in the majority of adult mouse tissues (Schuebel 1996) , thus suggesting that Vav-2 may play the same role as Vav in cell of non-hematopoietic lineage. Since Cbl-b is also ubiquitously distributed, it is likely that this protein plays a common regulatory role in all the cells in which it is expressed by interacting with either Vav (in hematopoietic cells) or Vav-2 (other cell types) proteins.
Cbl-b can also form complexes with the EGF and PDGF receptors in a ligand-and time-dependent manner. This association appears to be mediated by the formation of a trimeric complex with Vav, since such complexes could not be detected in the absence of Vav (unpublished observations). Interestingly, association of Cbl-b with these mitogenic receptors does not result in its phosphorylation on tyrosine residues. Since immunoprecipitations were conducted in the presence of sodium orthovanadate, this lack of phosphorylation cannot be attributed to dephosphorylation of Cbl-b by tyrosine phosphatases. These results indicate that Cbl-b behaves as some adaptor (Grb-2, p85) and eector (Sos) signal transduction molecules that are poor substrates for receptors with intrinsic protein tyrosine kinase activity. Unlike Cbl-b, the highly related c-Cbl protein becomes highly phosphorylated on tyrosine residues upon activation of a number of mitogenic and antigenic surface receptors (Langdon, 1995) . To date, the role of this tyrosine phosphorylation in the regulation of c-Cbl biological activity is unknown. However, an interesting inference from the lack of phosphorylation of Cbl-b obtained in our experiments is that the relevant physiological outcome of the association of Cbl proteins with activated receptors may not reside in their phosphorylation but, rather, in their translocation to the plasma membrane or in their association with other receptor-bound signaling molecules.
Critical information regarding the physiological role of the Sli/Cbl family of proteins has recently emerged from genetic studies in C. elegans aimed at identifying negative regulatory elements of the let23 signaling pathway (Yoon et al., 1995) . Null mutations in the sli-1 gene fully restore the viability, posterior epidermal development, male spicule formation and vulva induction of C. elegans mutants carrying reductionof-function mutations in the let23 gene (Yoon et al., 1995) . These mutants also rescue the vulvaless phenotype induced by reduction-of-function mutations of sem-5, the C. elegans homologue of the mammalian Grb-2 protein (Yoon et al., 1995) . These results suggest that Sli-1 plays an inhibitory role, hitherto uncharacterized, in the signaling pathway(s) that irradiate from the Let23 receptor (Yoon et al., 1995) .
The inhibitory role of mammalian c-Cbl is also suggested by recent experiments showing that the overexpression of c-Cbl downmodulates the allergic response mediated by the mast cell FceRI receptor. This eect appears to be mediated by its speci®c association with the protein tyrosine kinase Syk (Ota and Samelson, 1997) . Very recently, c-Cbl has been shown to become associated with Vav upon TCR activation in murine thymocytes and peripheral T cells (Marengere et al., 1997) . Whether the interaction of Vav with c-Cbl and Cbl-b has the same or dierent physiological consequences remains to be established. Other studies have also shown that c-Cbl can associate in dierent cell lineages with cytoplasmic tyrosine kinases and signal transduction molecules such as phosphatidylinositol 3-kinase (Langdon, 1995) . However, there is no evidence so far for an inhibitory role of c-Cbl on any of these enzymes.
Transduction of the cbl gene by a murine retrovirus results in the induction of pre-B lymphoma and myelogenous leukemia (Langdon, 1995) . It is possible that the c-Cbl protein acts as a negative regulator of mitogenic pathways in certain hematopoietic cells. If so, its oncogenic counterpart may act as a dominant negative mutant, liberating the infected cells from the proliferative constrains imposed by c-Cbl. Alternatively, c-Cbl may serve as a negative regulator of dierentiating and/or commitment pathways. In this scenario, the product of the v-cbl oncogene may constitutively block such pathways resulting in the constitutive proliferation of lymphoid and/or myeloid precursors.
We have recently demonstrated that expression of the oncogenic Vav protein leads to the stimulation of Rac-1 guanosine nucleotide exchange and to the activation of the downstream elements of the Rac-1 pathway such as the SEK/JNK cascade (Crespo et al,., 1996 (Crespo et al,., , 1997 . This stimulatory process appears to correlate to the signaling capabilities of Vav, since point mutations that eliminate the transforming activity of Vav also eliminate activation of Rac-1 and JNK (Crespo et al., 1996 (Crespo et al., , 1997 YPB2 yeast cells (MATa; 112 ; can R ; gal4-542; gal 80-538; LYS2 : : GAL1-HIS3, URA3 : : (GAL17mers)-lacZ) were used for all the two-hybrid experiments. E. coli MH4 strain (lacX74; galU; galK; hsr; rspL; leuB600) was used to recover library plasmids from yeast cells. E. coli DH5a cells were used for ampli®cation of plasmids and for induction of GST fusion proteins.
Materials and methods
Cells
Antibodies
A polyclonal rabbit antiserum raised against a MBP fusion protein containing the Dbl homology domain of the mouse Vav protein (residues 181 ± 449) was used for immunoprecipitation assays (Bustelo et al., 1995) . A rabbit polyclonal antiserum elicited against the cysteine rich region of Vav was used for Western blot analysis. Monoclonal antibodies against FLAG and HA epitopes were purchased from Kodak and Babco, respectively. A monoclonal antibody against the bacterial TrpE protein was obtained from Oncogene Science. Other immunological reagents included monoclonal antibodies against the bacterial GST protein (Santa Cruz) and anti-phosphotyrosine residues (Upstate Biotechnology).
Yeast two hybrid system YPB2 cells were transformed to tryptophan prototrophy with pXRB26 (Bustelo et al., 1995) by the alkaline method (Ito et al., 1983) . A single Trp + colony from this transfection was grown in SC-Trp medium and transformed with a human B-cell cDNA library, as previously described (Bustelo et al., 1995) . After incubation for 1 week in the presence of 15 mM 3-AT, His + colonies were transferred onto Whatman-50 ®lters, permeabilized by freezing in liquid nitrogen (1 min) and thawed at room temperature. Filters were then overlaid on Whatman 3MM paper saturated with a lacZ/X-gal solution (60 mM Na 2 HPO 4 , 60 mM NaH 2 PO 4 , 10 mM KCl, 1 mM MgSO 4 , 50 mM b-mercaptoethanol and 0.5 mg/ml of 4-nitrophenyl b-D-galactoside (Boehringer-Mannheim)) and incubated at 308C. Positive colonies were patched onto a master plate and analysed further. Total DNA from yeast cells was prepared according to the method of Homan and Winston (1987) and used to transform E. coli MH4 cells via electroporation using a Bio-Rad GenePulser. Transformants were plated on minimal medium supplemented with ampicillin. Primary positives were tested for target speci®city by re-transformation into the test strain in conjunction with a number of unrelated fusion proteins to either the DNA binding domain or the activator region of Gal4. The speci®city of the interaction of the positive clones was further assessed using two other independent assays, GST pull down and farwestern blot experiments, as previously described (Bustelo et al., 1995) . Only those clones that were positive under the three independent experimental conditions were considered as truly positives and selected for further study.
Cloning of cbl-b cDNA
The cDNA insert of pXRB85 was liberated by XhoI digestion and used as a probe to screen &4.2610 5 p.f.u. of a human embryonic brain cDNA library generated using random oligonucleotides (Stratagene). A total of nine phage cDNA clones were isolated, converted onto plasmid form by the addition of a helper phage, and characterized by restriction mapping. Six clones containing additional 5' (pXRB101, pXRB103, pXRB104 and pXRB105) and 3' sequences (pXRB85L and pXRB102) were further characterized by sequencing analysis. These analysis indicated that pXRB103 contained all the coding sequence of the Cblb protein whereas pXRB89L and pXRB104 contained two distinct forms of a dierentially spliced 3' end (data not shown). pXRB101 and pXRB105 were identical to pXRB103 with the exception of the 5' end which contained junk DNA ssequences composed mostly of Alu repetitive sequences (data not shown). Complete sequence analysis was performed with overlapping oligonucleotides that annealed to both strands of the cDNAs using a Taq-polymerase/dyeterminator (Perkin-Elmer) PCR ampli®cation technique.
Labeled fragments were separated by electrophoresis using ablot analysis using the same antibodies to demonstrate the equal expression in all samples of JNK, Vav and Cbl-b, respectively.
